21 research outputs found
The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
Apolipoprotein F (apoF) is 29 kilodalton secreted sialoglycoprotein that resides on the HDL and LDL fractions of human plasma. Human ApoF is also known as Lipid Transfer Inhibitor protein (LTIP) based on its ability to inhibit cholesteryl ester transfer protein (CETP)-mediated transfer events between lipoproteins. In contrast to other apolipoproteins, ApoF is predicted to lack strong amphipathic alpha helices and its true physiological function remains unknown. We previously showed that overexpression of Apolipoprotein F in mice reduced HDL cholesterol levels by 20β25% by accelerating clearance from the circulation. In order to investigate the effect of physiological levels of ApoF expression on HDL cholesterol metabolism, we generated ApoF deficient mice. Unexpectedly, deletion of ApoF had no substantial impact on plasma lipid concentrations, HDL size, lipid or protein composition. Sex-specific differences were observed in hepatic cholesterol content as well as serum cholesterol efflux capacity. Female ApoF KO mice had increased liver cholesteryl ester content relative to wild type controls on a chow diet (KO: 3.4+/β0.9 mg/dl vs. WT: 1.2+/β0.3 mg/dl, p<0.05). No differences were observed in ABCG1-mediated cholesterol efflux capacity in either sex. Interestingly, ApoB-depleted serum from male KO mice was less effective at promoting ABCA1-mediated cholesterol efflux from J774 macrophages relative to WT controls
Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter
High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets
Lipoprotein Composition in ApoF KO mice.
<p>Lipoproteins were isolated from one milliliter of pooled mouse plasma by KBr density gradient ultracentrifugation as follows: VLDL d<1.006, IDL/LDL 1.006</p
The effect of cholesterol loading and depletion on plasma lipids in ApoF KO mice.
<p>ApoF wild type (WT) and knockout (KO) mice (9β10 weeks of age) were fed a chow diet supplemented with either 0.01% ezetimibe or 0.2% cholesterol for 11 days. Values are reported as mean +/β standard deviation.</p>*<p>P<0.05 relative to WT for each treatment group.</p
The effects of High fat feeding on plasma lipids in ApoF deficient mice.
<p>Female ApoF wild type (WT), heterozygous (Het), and knockout (KO) mice were bled for baseline lipid measurements and placed on a diet containing 45% kcal from fat for 9 weeks. Plasma was then collected after 2, 4, and 9 weeks on the diet. All mice were fasted 4 hours before bleeding at every time point. Values are reported as the mean +/β standard deviation for each group (WT nβ=β8, Het nβ=β10, KO nβ=β8).</p><p>
<b><u>Two Way ANOVA Results:</u></b></p><p>Cholesterol: Time p<0.0001.</p><p>HDL-C: Time p<0.0001.</p><p>Non HDL-C: Time p<0.0001.</p><p>Triglycerides: Time n.s.,Genotype pβ=β0.0025 (Bonferroni vs WT: * p<0.05, ** p<0.01).</p><p>CE: Interaction pβ=β0.0428, Time p<0.0001.</p><p>Free Chol: Time p<0.0001, Genotype pβ=β0.0003 (Bonferroni WT vs KO *p<0.05).</p